Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • 3CX Reviews & Ratings
    4.4 out of 5 stars 1,237 Ratings
    Company Website for 3CX
  • Scotch Reviews & Ratings
    5.0 out of 5 stars 2 Ratings
    Company Website for Scotch
  • AnalyticsCreator Reviews & Ratings
    4.6 out of 5 stars 46 Ratings
    Company Website for AnalyticsCreator
  • EZO AssetSonar Reviews & Ratings
    4.5 out of 5 stars 118 Ratings
    Company Website for EZO AssetSonar
  • SBS Asset Finance Reviews & Ratings
    4.7 out of 5 stars 3 Ratings
    Company Website for SBS Asset Finance
  • The Asset Guardian EAM (TAG) Reviews & Ratings
    4.4 out of 5 stars 22 Ratings
    Company Website for The Asset Guardian EAM (TAG)
  • Vantage Reviews & Ratings
    4.4 out of 5 stars 15,963 Ratings
    Company Website for Vantage
  • Fixed Asset Pro Reviews & Ratings
    4.5 out of 5 stars 215 Ratings
    Company Website for Fixed Asset Pro
  • Air Reviews & Ratings
    4.6 out of 5 stars 849 Ratings
    Company Website for Air
  • OpenMetal Reviews & Ratings
    4.4 out of 5 stars 41 Ratings
    Company Website for OpenMetal

What is Koia?

We specialize in locating, verifying, and acquiring rare assets that are typically difficult to source. Each asset is meticulously secured in specific facilities such as bonded warehouses for wine or safety deposit boxes for watches, and we also oversee their insurance coverage. Our system generates 'Fractions' linked to these tangible assets, enabling the creation of hundreds or even thousands of individual Fractions that can be collected, traded, and valued over time. These Fractions are introduced for initial purchase via our app, allowing each user to acquire up to 100 unique Fractions during each release event. When you choose to sell your Fractions, you have the option to do so on any NFT marketplace, or you can decide to receive a share of the profits when a buyout offer is made and accepted by the token holders. Our mission is to create fresh opportunities, not only in asset acquisition but also in educational initiatives. By promoting a clear and accessible platform, we strive to break down traditional barriers and facilitate the growth of a fractional economy that is advantageous for all participants. This innovative model significantly enhances the way individuals engage with asset ownership, offering unprecedented access and opportunities. Ultimately, we believe our approach can revolutionize how people perceive and participate in investments.

What is Genomenon?

Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.

Media

Media

Integrations Supported

Integrations Supported

Google Cloud Platform

API Availability

API Availability

Has API

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Not specified

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Koia

Date Founded

2021

Company Location

United Kingdom

Company Website

www.joinkoia.com

Company Facts

Organization Name

Genomenon

Company Location

United States

Company Website

www.genomenon.com/pharma/

Categories and Features

Fractional Ownership

Not specified

Categories and Features

Drug Discovery

Not specified

Healthcare AI

Not specified

Popular Alternatives

Popular Alternatives

VSClinical Reviews & Ratings

VSClinical

Golden Helix